Status:
UNKNOWN
Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants Patients
Lead Sponsor:
Grupo de Estudos Multicentricos em Onco-Hematologia
Collaborating Sponsors:
Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Conditions:
Oral Hemorrhage
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Patients using anticoagulants present an increased risk of bleeding when subjected to oral surgery. Suspending or reducing the oral anticoagulant dose to perform invasive procedures, may result in thr...
Detailed Description
All patients will be submitted to clinical and radiographic examination. Once selected, patients will receive hygiene instruction and will be submitted to full mouth scaling one week before the proced...
Eligibility Criteria
Inclusion
- Patients over 18 years of age, use of warfarin sodium with or without anti-platelet aggregation, indicating simple extractions whose INR values are between 2.0 and 4.0 and that consent to participate in the study.
Exclusion
- Patients with platelet count \< 50,000 / mm3 Pregnant women or lactating Patients with hypersensitivity to the components of EACA. Patients with coagulopathies Patients who have impacted teeth, ankylosed or root morphological alterations that may complicate the procedure Patients who fail to submit laboratory and radiographic examinations necessary for the surgery
Key Trial Info
Start Date :
December 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2015
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT02238288
Start Date
December 1 2013
End Date
July 1 2015
Last Update
September 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clementino Fraga Filho University Hospital
Rio de Janeiro, Rio de Janeiro, Brazil, 21864-440